Shared compound evidence record
Tirzepatide (40mg)
Weight Management
In Stock
Tirzepatide
20mg Lyophilised Powder
$149.99AUD per vial
1
1 vial · Item total$149.99 AUD
Free express shipping Australia-wide
No account needed. PayID or bank transfer instructions follow checkout.
Labelled quantity
20mg
Category
Weight Management
Volume Savings
Availability
Ready to purchase now
In stock now and ready for checkout.
Next business day dispatch cutoff
Order within the current dispatch window
Melbourne cut-off time updates live every second.
Time Remaining
23:11:43
Associated report summary: 99.505% purity reported
Catalogue-associated report; current inventory-lot match not established.
Frequently Bought Together
Stable research navigation
Connected catalogue records
These links are based on catalogue family, evidence records, research topics and bundle composition. They do not imply therapeutic similarity.
Connected compound evidence
Retatrutide (10mg)
Weight Management
Connected compound evidence
Retatrutide (20mg)
Weight Management
Connected compound evidence
Retatrutide (30mg)
Weight Management
Connected compound evidence
Tesamorelin (10mg)
Weight Management
Connected compound evidence
Retatrutide Starter Bundle
Weight Management
Research library
Evidence and analytical context for this record
These resources separate compound identity, batch-quality questions and study evidence. A linked study does not establish that this catalogue material is equivalent to a medicine or investigational product.
Product Information
Tirzepatide (20mg) — Dual-Incretin Metabolic Research
Tirzepatide is a synthetic peptide that activates both GIP and GLP-1 receptors, providing a dual-pathway model for studying incretin biology. The 20mg format supports controlled investigation of receptor signalling, nutrient-response pathways and metabolic regulation.
Key Research Areas
- Dual-Receptor Signalling — Comparative study of combined GIP and GLP-1 receptor activity
- Glucose Homeostasis — Investigation of glucose-dependent insulin signalling and glycaemic-response pathways
- Appetite Biology — Models involving satiety signalling and gastric-emptying mechanisms
- Adipose Metabolism — Research into insulin sensitivity, lipid handling and body-composition pathways
- Incretin Comparisons — A dual-agonist reference for comparison with single- and triple-receptor compounds
Supplied as a nominal 20mg lyophilised powder. The current documented batch is reported at 99.505% purity, with batch-specific analytical information available in our CoA Library and fast domestic shipping across Australia.
For in-vitro research and laboratory use only. Not for human or veterinary use or consumption.
Frequently Asked Questions
What is Tirzepatide?
Tirzepatide is a synthetic dual agonist of the GIP and GLP-1 receptors. Researchers use it as a two-pathway model for investigating incretin signalling, glucose-dependent metabolic responses, gastric-emptying mechanisms and adipose biology.
How is Tirzepatide different from Semaglutide?
Semaglutide is a GLP-1 receptor agonist, whereas Tirzepatide combines GLP-1 and GIP receptor activity. That distinction makes Tirzepatide relevant to comparative studies of single- versus dual-incretin signalling.
How does Tirzepatide work?
Tirzepatide engages GIP and GLP-1 receptors in the same experimental system. Its research profile spans glucose-dependent insulin signalling, nutrient-response pathways, gastric emptying, satiety signalling and lipid-handling models.
What results has Tirzepatide shown in research?
Published research programs have examined Tirzepatide across body-composition, glycaemic-response and cardiometabolic endpoints. Those results have also made its dual-receptor profile a common comparator in studies of newer multi-receptor compounds.
How does Tirzepatide compare to Retatrutide?
Tirzepatide activates GIP and GLP-1 receptors, while Retatrutide adds glucagon-receptor activity as a third pathway. This makes the two compounds useful mechanistic comparators in multi-receptor metabolic research.
How do you reconstitute Tirzepatide?
Tirzepatide is supplied as a lyophilised powder and should be prepared with an appropriate laboratory-grade solvent under controlled research conditions. Follow the study protocol, batch documentation and institutional handling requirements.
How should Tirzepatide be stored?
Store lyophilised Tirzepatide according to the batch documentation and the requirements of the study protocol. Protect the research material from light and moisture, and use validated laboratory storage procedures after preparation.
Where to buy Tirzepatide in Australia?
Tirzepatide (20mg) is available through AUS Peptide Supply with domestic shipping to all Australian states and territories. Each batch is supported by analytical documentation in our CoA Library.
What is the availability and cost of Tirzepatide?
Tirzepatide (20mg) is currently in stock at AUS Peptide Supply and available for domestic dispatch across Australia. Tirzepatide (20mg) is priced at $149.99 AUD per vial at AUS Peptide Supply. Check this page's analytical-document status and the CoA library for published records.
How to get Tirzepatide online?
When inventory is available, add Tirzepatide (20mg) to your cart and complete checkout through the secure storefront. Orders are fulfilled domestically and shipped with tracking across Australia.